Skip to content
MMJ Gazette
  Monday 4 August 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
August 3, 2025Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves August 2, 2025Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E August 2, 2025Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn July 31, 2025Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off July 30, 2025Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal July 30, 2025Starting a Cannabis Business? Here’s What You Really Need to Know First July 29, 2025New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle? July 29, 2025Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate July 28, 2025Cannabis Shops Are Getting a Makeover – and Sales Are Going Up July 26, 2025State Attorneys General Push Congress to Fix Outdated Marijuana Banking Laws
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Marijuana  Organigram Secures Final Tranche of CA$124.6M Investment, Expanding Global Cannabis Ambitions
MarijuanaNews

Organigram Secures Final Tranche of CA$124.6M Investment, Expanding Global Cannabis Ambitions

Lars BeckersLars Beckers—March 7, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Canadian cannabis producer Organigram Holdings has wrapped up the last tranche of a CA$124.6 million ($87 million) investment from British American Tobacco’s subsidiary, BT DE Investments. This marks a major financial boost for Organigram as it looks to expand internationally through its strategic Jupiter investment fund.

British American Tobacco’s Deepening Stake in Organigram

This latest tranche saw BT DE Investments acquire 7.6 million common shares and 5.3 million Class A preferred shares at a price of CA$3.2203 per share, injecting CA$41.5 million into Organigram. The investment is part of a larger funding deal aimed at fueling long-term cannabis innovation and global expansion.

British American Tobacco (BAT) first took a stake in Organigram in 2021 and has been steadily increasing its investment. The move signals the tobacco giant’s confidence in Organigram’s market position and long-term potential, especially in cannabis-based consumer products.

Jupiter Fund: Organigram’s Key to U.S. and Global Expansion

With the Jupiter fund now fully funded, Organigram has an extra CA$57.8 million available for strategic investments. The company has already deployed CA$21 million into Germany-based Sanity Group, a medical cannabis operator, and CA$2.7 million into Open Book Extracts, a cannabinoid manufacturer in North Carolina.

The Jupiter initiative is structured to:

  • Accelerate Organigram’s entry into emerging cannabis markets, especially in Europe and the U.S.
  • Provide funding to promising cannabis and hemp businesses that struggle to access cost-efficient capital.
  • Strengthen Organigram’s product differentiation strategy in international markets.

De Luca: “Now Is the Time to Invest”

Paolo De Luca, Organigram’s Chief Strategy Officer, emphasized that the current cannabis market presents a prime opportunity for investments.

“Opportunities in the space have only improved with cannabis valuations at historically weaker levels and many cannabis and hemp companies unable to access cost-efficient growth capital despite fundamentally strong businesses,” De Luca stated.

This suggests Organigram sees the current downturn in cannabis stock prices as a chance to acquire valuable assets at a discount, positioning itself for long-term success.

Organigram’s Market Position and Stock Performance

Organigram, headquartered in New Brunswick, Canada, remains one of the few cannabis companies with strong international ambitions. Its shares are traded on both the Nasdaq and the Toronto Stock Exchange (OGI).

With its new capital reserves and the Jupiter fund at full strength, Organigram is poised to execute more strategic acquisitions and partnerships. The next steps could involve additional U.S. investments, pending regulatory clarity, and expanding its footprint in the European medical cannabis market.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Missouri Supreme Court to Rule on Marijuana Sales Tax Dispute
Texas Senator Pushes to Expand Medical Marijuana While Targeting Hemp THC Ban
Related posts
  • Related posts
  • More from author
Cannabis

Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves

August 3, 20250
Marijuana

Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E

August 2, 20250
Marijuana

Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn

August 2, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves
  • Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E
  • Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn
  • Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off
  • Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
  • Starting a Cannabis Business? Here’s What You Really Need to Know First
  • New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle?
  • Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate
  • Cannabis Shops Are Getting a Makeover – and Sales Are Going Up
  • State Attorneys General Push Congress to Fix Outdated Marijuana Banking Laws
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors